Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes—A Nationwide Cohort Study()()()

BACKGROUND: Increasing bodies of evidence suggest that metformin may be beneficial in the primary prevention of colorectal cancer (CRC), and a dose–response relationship has been reported. However, long-term epidemiological observations between the treatment period, cumulative dose, and intensity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yu-Tang, Tsai, Hsiang-Lin, Kung, Ya-Ting, Yeh, Yung-Sung, Huang, Ching-Wen, Ma, Cheng-Jen, Chiu, Herng-Chia, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884217/
https://www.ncbi.nlm.nih.gov/pubmed/29524831
http://dx.doi.org/10.1016/j.tranon.2018.02.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884217/
https://www.ncbi.nlm.nih.gov/pubmed/29524831
http://dx.doi.org/10.1016/j.tranon.2018.02.012

Ejemplares similares